D. Studer

Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism

S. Wasiak, N. Wong, B. Rakai, 2019, Clinical Epigenetics.

Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism

S. Wasiak, N. Wong, B. Rakai, 2019, Clinical Epigenetics.

Linking Aortic Mechanical Properties, Gene Expression and Microstructure: A New Perspective on Regional Weakening in Abdominal Aortic Aneurysms

Elena S. Di Martino, Randy D. Moore, R. Shepherd, 2021, Frontiers in Cardiovascular Medicine.

The BET inhibitor apabetalone decreases neuroendothelial proinflammatory activation in vitro and in a mouse model of systemic inflammation

B. Rakai, K. Rinker, S. Stotz, 2023, Translational neuroscience.